Figure 2.
Figure 2. Overexpression of Bcl-xL prevents BCR- or arachidonic acid–mediated apoptosis, but not growth arrest, in WEHI-231 immature B cells. Growth arrest was assessed by measurement of anti-Ig- or arachidonic acid–mediated suppression of DNA synthesis by WEHI-231 B cells. (A) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 0 to 10 μg/mL anti-IgM or anti-IgM plus anti-CD40 (aIg + aCD40, both at 10 μg/mL), and levels of [3H]-thymidine incorporation into DNA were measured. (B) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 0 to 100 μM arachidonic acid or 10 μg/mL anti-IgM, and levels of [3H]-thymidine incorporation into DNA were measured. Data are expressed as means ± SD (n = 3) from single experiments representative of at least 2 other independent experiments. (C) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 100 μM arachidonic acid (AA), 10 μg/mL of anti-IgM (aIg), 10 μg/mL anti-CD40 (aCD40), or anti-IgM plus anti-CD40 (aIg/CD40, both at 10 μg/mL), and percentages of apoptotic cells were determined. Data are expressed as means ± SEM and are pooled from up to 13 individual experiments. (D) WEHI-231-Neo (open symbols) or WEHI-231Bcl-xL (filled symbols) B cells were treated for up to 72 hours with medium (squares), 100 μM arachidonic acid (circles), or 10 μg/mL anti-IgM (diamonds) before determining the resulting levels of apoptosis. Apoptosis was measured by propidium iodide (PI) staining of subdiploid DNA content as described in “Materials and methods.”

Overexpression of Bcl-xLprevents BCR- or arachidonic acid–mediated apoptosis, but not growth arrest, in WEHI-231 immature B cells. Growth arrest was assessed by measurement of anti-Ig- or arachidonic acid–mediated suppression of DNA synthesis by WEHI-231 B cells. (A) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 0 to 10 μg/mL anti-IgM or anti-IgM plus anti-CD40 (aIg + aCD40, both at 10 μg/mL), and levels of [3H]-thymidine incorporation into DNA were measured. (B) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 0 to 100 μM arachidonic acid or 10 μg/mL anti-IgM, and levels of [3H]-thymidine incorporation into DNA were measured. Data are expressed as means ± SD (n = 3) from single experiments representative of at least 2 other independent experiments. (C) WEHI-231-Neo (□) or -Bcl-xL (▪) B cells were treated for 48 hours with 100 μM arachidonic acid (AA), 10 μg/mL of anti-IgM (aIg), 10 μg/mL anti-CD40 (aCD40), or anti-IgM plus anti-CD40 (aIg/CD40, both at 10 μg/mL), and percentages of apoptotic cells were determined. Data are expressed as means ± SEM and are pooled from up to 13 individual experiments. (D) WEHI-231-Neo (open symbols) or WEHI-231Bcl-xL (filled symbols) B cells were treated for up to 72 hours with medium (squares), 100 μM arachidonic acid (circles), or 10 μg/mL anti-IgM (diamonds) before determining the resulting levels of apoptosis. Apoptosis was measured by propidium iodide (PI) staining of subdiploid DNA content as described in “Materials and methods.”

Close Modal

or Create an Account

Close Modal
Close Modal